Stockreport

Dyne: H2 2024 Muscle Disease Data Could Boost Value [Seeking Alpha]

Dyne Therapeutics, Inc.  (DYN) 
Last dyne therapeutics, inc. earnings: 11/1 04:30 pm Check Earnings Report
US:NYSE Investor Relations: dynegy.com/investors/presentations-events
PDF The Myotonic Dystrophy Type 1 treatment market is expected to reach $2.78 billion by 2033. The global Duchenne Muscular Dystrophy treatment market is expected to reac [Read more]